|
Re: Her3
Fluffqueen (love the name),
I seem to recall in my estrogen deprived, chemo-brain, that being highly Her2 positive makes us typically more responsive to Herceptin. Now your question of whether it makes us more susceptible to recurrence, I cannot recall. Perhaps they do not yet know. There are several variables that affect our response to Herceptin such as whether we are Her3 overexpressors.
I think the take away of the above is to live your life. Cancer gets further in your rear view mirror as time passes. It's forever there, an ever present pall on our futures, but as time passes you will look up into your rear view mirror less and less. What will be will be. Live and enjoy.
__________________
Smile On!
Laurel
Dx'd w/multifocal DCIS/IDS 3/08
7mm invasive component
Partial mast. 5/08
Stage 1b, ER 80%, PR 90%, HER-2 6.9 on FISH
0/5 nodes
4 AC, 4 TH finished 9/08
Herceptin every 3 weeks. Finished 7/09
Tamoxifen 10/08. Switched to Femara 8/09
Bilat SPM w/reconstruction 10/08
Clinical Trial w/Clondronate 12/08
Stopped Clondronate--too hard on my gizzard!
Switched back to Tamoxifen due to tendon pain from Femara
15 Years NED
I think I just might hang around awhile....
|